DENVER, Mar 27, 2014 (BUSINESS WIRE) — An outbreak of the deadly Ebola virus in West Africa has promptedCorgenix Medical CorporationCONX -12.64% to extend its existing viral hemorrhagic fever (VHF)

rapid test development to include the Ebola virus. Corgenix has already developed and CE marked a rapid test for the Lassa fever virus, another member of the VHF group of viruses.

Subscribe To Our VSL Newsletter

Join our mailing list to receive the latest Sierra Leone travel and tourism news and updates from our team.

You have Successfully Subscribed!

Share This